Harrow Health, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on December 11, 2019, by Harrow Health, Inc. (HROW), a Delaware corporation. The report addresses "Other Events" (Item 8.01) concerning a legal dispute with Novel Drug Solutions, LLC and Eye Care Northwest, PA (collectively "NDS").
Financial Metrics
The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on a legal contingency rather than financial performance.
Material Changes and Legal Contingencies
- Legal Dispute: The Company is involved in a lawsuit with NDS regarding a terminated Asset Purchase Agreement.
- Allegations: On December 10, 2019, NDS issued a press release containing statements the Company deems false and misleading, including alleged violations of a federal court order.
- Company Position: Harrow Health believes the remaining claims in the lawsuit are meritless.
Management Commentary and Outlook
Management explicitly states that the lawsuit with NDS and the termination of the Asset Purchase Agreement are not expected to affect the Company's ImprimisRx business. Specifically, operations, revenues, and the ongoing service of customers are anticipated to remain unaffected.
Key Facts for Investor Verification
- Verify the status of the lawsuit between Harrow Health and NDS regarding the terminated Asset Purchase Agreement.
- Confirm the details of the federal court order allegedly violated by NDS in their December 10, 2019 press release.
- Monitor future filings for any updates on the legal proceedings or potential financial impact on the ImprimisRx segment.